Why it Matters
Millions of Americans struggle to afford their prescriptions.
From 2012 – 2017 prices of brand name drugs increased 10% annually.
Drugs with varying clinical value are being introduced.
The details:
- Value-based arrangements (VBAs) can help lower costs and improve health outcomes for patients in the commercial health insurance market by connecting payment for a drug to its value.
- Few VBAs exist between drug manufacturers and commercial health plans because the Medicaid Best Price rule presents significant financial risk to drug manufacturers.
- However, the Medicaid Best Price rule plays an important role in making prescription drugs affordable and accessible for Medicaid beneficiaries.
VBAs Benefit Those Who:
Experience Care
Patients may have better access to more affordable drugs that offer the best value, including innovative curative therapies.
Provide Care
Patients’ access to costly treatments may be improved.
Pay for Care
Payers may achieve reductions in costs for consumers, and employers will be able to better manage risk.
Discover More
Insights & Solutions
We are committed to leading in the development of the next-generation health system in a socially conscious way and driving distinguished societal return by improving health care access and affordability, enhancing the health care experience and achieving better health outcomes for the individuals and organizations we are privileged to serve.
Be The First to Know.
Share This Story